20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease

MLA

Sayaka Nagata, et al. “20 KDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease.” Gastrointestinal Disorders, vol. 2, no. 33, Oct. 2020, pp. 366–77. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c6e8736c9161d345457f1c75bf4250d&authtype=sso&custid=ns315887.

APA

Sayaka Nagata, Masaji Tamura, Kumiko Yoshizawa-Kumagaye, Joji Kato, Mariko Tokashiki, Goro Miki, Taku Yoshiya, Kazuo Kitamura, Shinya Ashizuka, Nobuko Kuroishi, & Motoo Yamasaki. (2020). 20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease. Gastrointestinal Disorders, 2(33), 366–377.

Chicago

Sayaka Nagata, Masaji Tamura, Kumiko Yoshizawa-Kumagaye, Joji Kato, Mariko Tokashiki, Goro Miki, Taku Yoshiya, et al. 2020. “20 KDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease.” Gastrointestinal Disorders 2 (33): 366–77. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c6e8736c9161d345457f1c75bf4250d&authtype=sso&custid=ns315887.